Swan Capital’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26K Sell
17
-11
-39% -$1.94K ﹤0.01% 354
2026
Q1
$4.97K Hold
28
﹤0.01% 258
2025
Q4
$3.91K Sell
28
-25
-47% -$2.84K ﹤0.01% 263
2025
Q3
$4.27K Buy
53
+8
+18% +$617 ﹤0.01% 234
2025
Q2
$2.82K Hold
45
﹤0.01% 293
2025
Q1
$3.24K Hold
45
﹤0.01% 212
2024
Q4
$3.87K Buy
45
+25
+125% +$2.49K ﹤0.01% 192
2024
Q3
$1.89K Hold
20
﹤0.01% 227
2024
Q2
$1.91K Buy
+20
New +$2.38K ﹤0.01% 199

Other funds holding ALB

Swan Capital's ALB Position: Q2 2026 in Review

Swan Capital reduced its Albemarle (ALB) stake by 39% in Q2 2026, selling an estimated $1.94K and leaving 17 shares worth $2.26K. The position accounts for ﹤0.01% of the portfolio, ranked #354.

Swan Capital first reported a position in ALB in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.97K in Q1 2026. 942 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Swan Capital held 17 shares of Albemarle worth $2.26K as of Q2 2026.
  • Swan Capital sold 11 Albemarle shares in Q2 2026, an estimated $1.94K.
  • Albemarle made up ﹤0.01% of Swan Capital's portfolio in Q2 2026, its #354 holding.
  • Swan Capital first reported a position in Albemarle in Q2 2024 and has held it in 9 quarters since.
  • Swan Capital's Albemarle position peaked at $4.97K in Q1 2026.
  • 942 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.